Stroke risk

The risk of recurrent stroke in people who have had an ischaemic stroke or transient ischaemic attack (TIA) is high (10% at one week, 14% at one month and 18% at three months). To reduce the relative risk of further vascular events:

Source: Practical Neurology 2008;8:141-157.
 

A summary of national recommendations for secondary prevention of further vascular events in patients who have already experienced a stroke or TIA. Most of these recommendations are also applicable to patients with established CHD.

 

Antiplatelet therapy

ALL patients not on anticoagulation should be prescribed an antiplatelet agent after an ischaemic stroke (or other vascular event) to prevent further stroke or vascular events.

Hypertension

Initiate drug therapy in ALL stroke patients with sustained SBPs >140mmHg or DBPs >90mmHg despite non-pharmacological measures. 

Treatment targets

  Clinic BP (mmHg) Mean day-time ABPM or home BP
No diabetes Diabetes No diabetes Diabetes
Optimal BP <140/85 <140/80 <130/80 <130/75
Audit standard <150/90 <140/85 <140/85 <140/85

The audit standard reflects the minimum recommended level of BP control. Despite best practice, it may not be achievable in all hypertensives. SBP = systolic blood pressure DBP = diastolic blood pressure ABPM = ambulatory blood pressure monitor.

Hyperlipidaemia

Therapy with a statin should be considered for all patients with a past history of Ml and a cholesterol >5.0 mmol/L following stroke. Statins and dietary advice should be given to lower serum cholesterol concentrations EITHER to <5.0 mmol/l (LDL-cholesterol to <3.0 mmol/l) OR by 30% (whichever is greater).

Diabetes

Ensure meticulous control of glucose and blood pressure in patients with diabetes.

Anticoagulation

Anticoagulation should be - started in every patient in atrial fibrillation (valvular or non-valvular) unless contraindicated - considered for all patients who have ischaemic stroke associated with mitral valve disease, prosthetic heart valves, or within 3 months of Ml An INR of 2.5 + 0.5 is considered optimal

Lifestyle

ALL patients should be offered information and personalised advice about how they can reduce their modifiable risk factors. 

Links


References

  1.  Department of Health. Notional Service Framework for Coronary Heart Disease. Department of Health: London, March 2000 
  2. Department of Health. Saving Lives: Our Healthier Nation. HMSO, Cm4386, July 1999 
  3. The Royal College of Physicians. Natianal Clinical Guidelines for Stroke. London, 2000 
  4. Wood 0 eta1. Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart 1 998;80 ISuppi 2):S1 -S26 
  5. Ramsay LE eta1. Guidelines for management of h pertension: report of the third working party of the British Hypertension Society. J Hum Hypertension 1 999;1 3:569-92 
  6. Wolf PA et al. Cigarette smoking as a risk factor for stroke: the Framingham study. JAMA 1 988;259: 1025-29
  7. Stroke Management (Northumberland guidelines - NHSnet only)